John Maudsley PhD

Dr. John Maudsley is an immunologist with a BSc and Ph.D. from University College London. He spent some years in immunology research at Warwick University, within the Virus Group. His focus over many years has been on the development of cancer vaccines.

John has a background in cellular Immunology having done his Ph.D. with Avion Mitchison FRS and Sir Marc Feldmann at the Imperial Cancer Research Fund Tumour Immunology Unit at University College London. He was a senior research fellow at the University of Warwick and the founding Chairman of the British Society’s West Midland Immunology Group. In 1999 he founded Cancer Vaccines Ltd based at Coventry University Technology Park to develop cell-based allogeneic immunotherapies for treating cancer. He is responsible for the scientific and technological direction of the research. Cancer Vaccines Ltd has made considerable progress in developing cell-based immunotherapies and is currently in the early stages of a clinical trials program. John is also involved in research developing a technology to protect and immunize people against airborne infections with particular potential in the event of a pandemic.